Merck & Co., Inc. is a New Jersey corporation that sells prescription medicines, biologic therapies, vaccines and animal health products worldwide. Its corporate headquarters and principal executive offices are at 126 East Lincoln Avenue in Rahway, New Jersey. Its common stock trades on the New York Stock Exchange as MRK. The company’s contact page says that outside the United States and Canada Merck is known as MSD.
Identity
- Legal name (10-K cover): Merck & Co., Inc.
- Ticker and exchange: MRK, New York Stock Exchange
- State of incorporation: New Jersey
- SEC CIK: 0000310158 (SEC file number 1-6571)
- Fiscal year end: December 31
- Category: Pharmaceuticals and life sciences; prescription medicines, vaccines and animal health
Segments and 2025 sales
The Form 10-K for the year ended December 31, 2025 reports total sales of $65,011 million and two reportable segments, Pharmaceutical and Animal Health. The Pharmaceutical segment covers human health pharmaceutical and vaccine products. The Animal Health segment covers veterinary pharmaceutical and vaccine products and health management solutions for livestock and companion animals. International sales were 44% of total sales in 2025.
| Segment / product line | 2025 sales (USD millions) |
|---|---|
| Pharmaceutical segment | 58,142 |
| Keytruda / Keytruda Qlex | 31,680 |
| Gardasil / Gardasil 9 | 5,233 |
| Januvia / Janumet | 2,544 |
| ProQuad / M-M-R II / Varivax | 2,451 |
| Bridion | 1,841 |
| Animal Health segment | 6,354 |
| Livestock | 3,896 |
| Companion Animal | 2,458 |
The 10-K states that Keytruda represented 49% of the company’s total sales in 2025. The segment lines above are the figures printed in the 10-K sales table; other revenues of $515 million make up the difference to the total.
Workforce and sites
As of December 31, 2025, Merck had approximately 75,000 employees worldwide, including approximately 30,000 in the U.S. and Puerto Rico, plus approximately 15,000 third-party contractors. The 10-K places the corporate headquarters and the headquarters of manufacturing operations in Rahway and a divisional headquarters in Upper Gwynedd, Pennsylvania. It lists principal U.S. research facilities in Rahway; West Point, Pennsylvania; Boston and Cambridge, Massachusetts; South San Francisco, California; and Elkhorn, Nebraska (Animal Health), and production facilities for human health products at five locations in the U.S. and Puerto Rico.
How to verify this company yourself
- SEC EDGAR filer page for Merck & Co., Inc. (CIK 0000310158)
- Form 10-K for fiscal year 2025 (cover page, Item 1 business, Item 2 properties)
- Merck official contact page (headquarters address, switchboard, National Service Center, investor and media contacts)
Location and contact
- Corporate headquarters (10-K cover): 126 East Lincoln Avenue, Rahway, NJ 07065
- Mailing address on the company contact page: 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065
- Main telephone (10-K cover; Monday to Friday, 9:00 a.m. to 5:00 p.m. ET per merck.com/contact-us): +1 908-740-4000
- Investor questions (merck.com/contact-us): +1 908-740-1468
- Merck National Service Center, product information and adverse events (merck.com/contact-us; Monday to Friday, 8:00 a.m. to 7:00 p.m. ET): +1 800-444-2080
- Website: merck.com
Last verified: November 6, 2026. Sources: Merck & Co., Inc. Form 10-K for fiscal 2025 (filed February 24, 2026); SEC EDGAR submissions record for CIK 0000310158; merck.com contact page.
Directory listing. Not investment advice, not a product review, and not medical advice. Product names and sales figures are those published in the company’s 10-K.
Listing type: Editorial. Not claimed by the company. Not sponsored. Send a correction.
